{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "36853035",
  "DateCompleted": {
    "Year": "2023",
    "Month": "06",
    "Day": "05"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "06",
    "Day": "05"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2023",
        "Month": "03",
        "Day": "05"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.3928/02793695-20230222-02"
    ],
    "Journal": {
      "ISSN": "0279-3695",
      "JournalIssue": {
        "Volume": "61",
        "Issue": "6",
        "PubDate": {
          "Year": "2023",
          "Month": "Jun"
        }
      },
      "Title": "Journal of psychosocial nursing and mental health services",
      "ISOAbbreviation": "J Psychosoc Nurs Ment Health Serv"
    },
    "ArticleTitle": "Electroconvulsive Therapy for Treatment-Resistant Depression: Dispelling the Stigma.",
    "Pagination": {
      "StartPage": "11",
      "EndPage": "17",
      "MedlinePgn": "11-17"
    },
    "Abstract": {
      "AbstractText": [
        "The current article is a comprehensive overview of electroconvulsive therapy (ECT) for treatment-resistant depression (TRD), especially with suicidality and psychosis. Common misconceptions and stigma associated with ECT are discussed. Major depressive disorder, one of the most prevalent lifetime mental disorders, is often associated with significant impairments that impacts one's ability to function. Antidepressants may be efficacious in treating depression; however, approximately one third of individuals do not respond to psychotropic medications. Therefore, other treatment options, such as ECT, must be considered for those who do not respond to medications, have psychosis, or are suicidal. [<i>Journal of Psychosocial Nursing and Mental Health Services, 61</i>(6), 11-17.]."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Salani",
        "ForeName": "Deborah",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Goldin",
        "ForeName": "Deana",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Valdes",
        "ForeName": "Beatriz",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "DeSantis",
        "ForeName": "Joseph",
        "Initials": "J"
      }
    ],
    "PublicationTypeList": [
      "Review",
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Psychosoc Nurs Ment Health Serv",
    "NlmUniqueID": "8200911",
    "ISSNLinking": "0279-3695"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antidepressive Agents"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Electroconvulsive Therapy"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Depressive Disorder, Major"
    },
    {
      "QualifierName": [
        "therapy"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Depressive Disorder, Treatment-Resistant"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antidepressive Agents"
    }
  ]
}